Yonhap Infomax NewsApr 17, 2025
Celltrion's cancer drug Herzuma secures extended supply in Brazil until 2026, strengthening its position in Latin American markets
#YonhapInfomax #Celltrion #Herzuma #BrazilSupply #CancerTreatment #LatinAmericanMarket #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=59080
Celltrion's Breast and Gastric Cancer Treatment Herzuma Extends Supply Period in Brazil

Celltrion's cancer drug Herzuma secures extended supply in Brazil until 2026, strengthening its position in Latin American markets

Yonhap Infomax